Floatz logo

Microcrystalline cellulose

Obesity

Promomed, LLCPhase 4 / ApprovedDormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
59/ 100

Competitive context

361 Active assets in the Obesity cohort.

Asset / SponsorPhaseRating
vi-0521
VIVUS LLC
Phase 4BBB
Phentermine
Russell McCulloh, MD
Phase 4BBB
Survodutide
Boehringer Ingelheim
Phase 3BBB
Cagrilintide
Novo Nordisk A/S
Phase 3BBB
Tirzepatide
Royal North Shore Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Microcrystalline cellulose is also rated in:

diabetic neuropathyDormant
D
Indicative ·
30 / 100
View asset →
insomniaDormant
D
Indicative ·
30 / 100
View asset →
obesity disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →